Abstract
To control attacks of vertigo while preserving both hearing and labyrinthine function, low doses of gentamicin were instilled intratympanically in nine patients with intractable unilateral Meniere's disease. Each patient received six instillations of antibiotic of 4 mg each (total dose, 24 mg). Patients were then followed for 2–4 years. Long-term results of treatment are reported according to the American Academy of Otolaryngology-Head and Neck Surgery 1985 criteria. Of the nine cases, three experienced complete control of vertiginous attacks, while six received substantial control. Post-treatment hearing acuity was unaffected, although disability following treatment became worse in one patient, a 66-year-old man. Caloric responses after therapy were absent or severely reduced in three ears, moderately reduced in two ears and unchanged in four ears. In three patients, labyrinthine function was found damaged 4–8 days after administration of the last dose of drug. Overall, intratympanic instillations of low doses of gentamicin in patients with intractable Meniere's disease were found to control vertiginous attacks with less damage to the inner ear function than that reported in the literature.
Similar content being viewed by others
References
Beck C, Schmidt C (1978) 10 years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of morbus Meniere. Arch Otorhinolaryngol 221:149–152
Laitakari K (1990) Intratympanic gentamycin in severe Meniere's disease. Clin Otolaryngol 15:545–548
Lange G (1981) Die Indikation zur intratympanalen Gentamycin-Behandlung der Meniereschen Krankheit. HNO 29:49–51
Möller C, Ödkvist LM, Thell J, Larsby B, Hyden D (1988) Vestibular and audiological functions in gentamicin-treated Meniere's disease. Am J Otol 9:383–391
Pearson BW, Brackman DE (1985) Editorial. Committee on Hearing and Equilibrium guidelines for reporting treatment results in Meniere's disease. Otolaryngol Head Neck Surg 93: 579–581
Pender DJ (1985) Gentamicin tympanoclysis: effects on the vestibular secretory cells. Am J Otolaryngol 6:358–367
Sala T (1988) Transtympanic administration of aminoglycosides in patients with Meniere's disease. Arch Otorhinolaryngol 245:293–296
Schuknecht HF (1957) Ablation therapy in the management of Meniere's disease. Acta Otolaryngol (Stockh) [Suppl] 132:1–42
Uemura T (1977) The caloric test. In: Uemura T, Suzuki J, Hozawa J, Highstein SM (eds) Neuro-otological examination. University Park Press, Baltimore, pp 68–80
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Inoue, H., Uchi, Y., Nogami, K. et al. Low-dose intratympanic gentamicin treatment of Meniere's disease. Eur Arch Otorhinolaryngol 251 (Suppl 1), S12–S14 (1994). https://doi.org/10.1007/BF02565212
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02565212